Madrid

• Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Partici … Ended
  2024-512586-13-00 1 Non-Hodgkin's Lymphoma
• Effect of Copper CU64 PSMA I&T scanning to detect potential disease spread to lymph nodes in men with newly diagnosed Prostate Cancer Ended
  2024-512754-16-01 5 Prostate cancer
• A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONS … Ended
  2024-512804-20-00 5 Metastatic Colorectal Cancer
• A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Abiprubart i … Ended
  2024-512986-15-00 4 Sjögren’s Disease
• Simvastatin in the Prevention of Recurrent Pancreatitis, a Triple Blind, Randomized Controlled Trial. Ended
  2024-513188-17-03 6 Recurrent pancreatitis
• CHRONOS - A study to learn about the effects and safety of ODM-111 in participants with long-lasting pain due to osteoarthritis of the knee. Ended
  2024-513553-79-00 4 Chronic Pain due to Ostheoarthritis of the knee
• A Phase 1a/1b Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-5 … Ended
  2024-514704-13-00 1 Advanced or Metastatic Solid Tumors with KRAS Mutations or Amplificati
• A Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Evidence of Antitumor Ac … Ended
  2024-515258-25-00 7 advanced solid tumors with KRAS G12C mutation
• A clinical study evaluating efficacy and safety of inupadenant in combination with carboplatin and pemetrexed in adults with metastatic nons … Ended
  2024-515393-27-00 4 Nonsquamous non-small cell lung cancer
• Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN) Ended
  2024-515813-17-00 5 Acute Respiratory Distress Syndrome (ARDS)
• DCC-3084 monotherapy in patients with solid tumors Ended
  2024-517829-12-00 7 Solid tumors driven by the MAPK Pathway
• C6081001: A Phase 1 Study of PF-07985045 in Participants with Advanced Solid Tumors Ended
  2024-517988-23-00 1 KRAS mutated advanced solid tumors
• A trial to find out how well CVHNLC works at different dose levels and how safe it is in combination with pembrolizumab in patients with lun … Ended
  2024-519651-28-00 1 metastatic squamous non-small cell lung cancer
• A Study of Valemetostat Tosylate Plus Pembrolizumab versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations Ended
  2024-519671-26-00 9 Advanced or Metastatic Non-Small Cell Lung Cancer
• A study to investigate the safety, tolerability, pharmacokinetics (PK), and preliminary anticancer activity of GSK4524101 alone or with nira … Ended
  2024-520197-36-00 7 Neoplasms
• Phase 2 study of inhaled SNG001 in mechanically ventilated patients with respiratory virus infection Ended
  2024-520375-27-00 4 Lower respiratory tract viral infections
• Study of the Effectiveness and Safety of Acasunlimab Alone or With Pembrolizumab in treating Advanced Melanoma of the Skin That Has Returned … Ended
  2025-520468-16-00 4 Cutaneous Melanoma, Relapsed/Refractory, Locally Advanced Unresectable
• A Study to Learn About the Study Medicine Called PF-07258669 in Older Adults Including Those at Risk of Malnutrition Ended
  2025-520763-41-00 3 Older adults at risk of malnutrition
• A PHASE II TRIAL EVALUATING THE SAFETY AND EFFICACY OF THE COMBINATION OF ZIMBERELIMAB, DOMVANALIMAB, AND SACITUZUMAB GOVITECAN AS FIRST-LIN … Ended
  2025-521489-80-00 4 PD-L1 POSITIVE ADVANCED TRIPLE-NEGATIVE BREAST CANCER
• A study of lifileucel (tumor-infiltrating lymphocytes) in adults with advanced melanoma Ended
  2025-522054-40-00 4 Previously treated advanced melanoma
• The ENACT Trial: A Randomized, double-blind, placebo-controlled adjunctive treatment trial to evaluate the efficacy and safety of ENX-101 in … Expired
  2022-501028-95-00 4 focal (partial onset) epilepsy
• A phase IV, unicentric, open label clinical trial to evaluate the default mode network in multiple sclerosis patients on Cladribine treatmen … Expired
  2023-504577-21-00 6 Multiple Sclerosis

Showing 3,529–3,550 of 3,550 trials